Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS

Clinical trial NCT04055844 · COMPLETED

Trial details

NCT number: NCT04055844
Sponsor: Masonic Cancer Center, University of Minnesota
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myeloid and Monocytic Leukemia Myelodysplastic Syndromes

Start date: 2020-02-17
Primary completion: 2022-09-06
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.